Compare BTOC & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BTOC | MBAI |
|---|---|---|
| Founded | 2020 | 2004 |
| Country | United States | Israel |
| Employees | N/A | 85 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9M | 12.0M |
| IPO Year | 2023 | N/A |
| Metric | BTOC | MBAI |
|---|---|---|
| Price | $0.28 | $1.81 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 196.1K | 150.9K |
| Earning Date | 05-24-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $190,408,258.00 | N/A |
| Revenue This Year | $34.89 | N/A |
| Revenue Next Year | $14.53 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 14.03 | N/A |
| 52 Week Low | $0.23 | $1.29 |
| 52 Week High | $1.78 | $3.92 |
| Indicator | BTOC | MBAI |
|---|---|---|
| Relative Strength Index (RSI) | 47.54 | 55.85 |
| Support Level | $0.27 | $1.35 |
| Resistance Level | $0.34 | $1.91 |
| Average True Range (ATR) | 0.02 | 0.17 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 21.44 | 61.73 |
Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.